- ... continuing Teseaich with non-nucleoside reverse transcriptase inhibitors, protease inhibitors, tat inhibitors, and nucleoside reverse transcriptase inhibitors. However, ...
- ... were brought by new drug development. The first protease inhibitors were available by 1996, and others followed rapidly. ...
- ... THEY EXPECT A 50% FAILURE RATE FOR ALL PROTEASE INHIBITORS The AIDS crisis is not over. give.work. ...
- NLM Digital Collections - The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the ...Publication: [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014Protease Inhibitors -- economics ... Protease Inhibitors -- therapeutic use ... introduction of first generation direct-acting antiviral (DAA) protease inhibitors boceprevir (Victrelis, Merck & Co.) and telaprevir (Incivek, Vertex ...
- ... ddC Castanospermine, Deoxynoyjirimycin Ribavirin GLQ.-233 Interferons, Ampligen, Protease inhibitors CD4-PE (CD4-pseudomonas exotoxin), CD4-deA (CD4. ... not severe and clinical trials are planned. Viral Protease Inhibitors: HIV’s gag gene product is processed into several ...
- NLM Digital Collections - The Health Consequences of Smoking: Chronic Obstructive Lung Disease: A Report of the Surgeon ...Publication: United States. Office on Smoking and Health, 1984... 80 percent of all PiZZ persons (where Pi= protease inhibitor) will develop lung disease. Larsson (1978) has projected ... as trypsin, may be negligible. The names a,-protease inhibitor or o1- proteinase inhibitor better describe this broader ...
- NLM Digital Collections - The Health Consequences of Smoking: Chronic Obstructive Lung Disease: A Report of the Surgeon ...Publication: United States. Office on Smoking and Health, 1984... particulate phase (Kilburn and McKenzie 1975). Effects on Protease Inhibitors In addition to efforts to characterize the effects ... delineating the effects of tobacco smoke on the protease ~ inhibitor defense mechanism in the lungs. While several protease ...
- NLM Digital Collections - Management of hepatitis C : a national clinical guidelinePublication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), July 2013... C to reflect the most recent evidence around protease inhibitor treatment as an adjunct to current standard dual ... weight-based ribavirin with the addition of a protease inhibitor as triple therapy. AAll treatment-experienced patients infected ...
- NLM Digital Collections - Beikoku Kokuritsu Igaku Toshokan bunruihō : igaku oyobi kanren bun'ya ni okeru tosho haikahōPublication: Tōkyō : Nihon Igaku Toshokan Kyōkai, 1996... As an enzyme inhibitor QU 143 alpha 1-Protease Inhibitor see alpha 1-Antitrypsin alpha 1-Proteinase Inhibitor ... Ciguatoxin QW 630 Cilastatin QU 90 As a protease inhibitor QU 136 Cilia QS 532.5.E7 In ...
- NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ...Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, D.C. : For sale by the Supt. of Docs., U.S. G.P.O., 1994... As an enzyme inhibitor QU 143 alpha 1-Protease Inhibitor see alpha 1-Antitrypsin alpha 1-Proteinase Inhibitor ... Ciguatoxin QW 630 Cilastatin QU 90 As a protease inhibitor QU 136 Cilia QS 532.5.E7 In ...
174 results